Skip to Content

WATSON 3700 (Ropinirole hydrochloride extended-release 6 mg)

Pill imprint WATSON 3700 has been identified as Ropinirole hydrochloride extended-release 6 mg.

Ropinirole is used in the treatment of parkinson's disease; restless legs syndrome; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 6 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ropinirole hydrochloride extended-release 6 mg WATSON 3700
Ropinirole hydrochloride extended-release 6 mg WATSON 3700
Discount Card Promo
Ropinirole hydrochloride extended-release
Imprint:
WATSON 3700
Strength:
6 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-3700
Inactive Ingredients:
hypromelloses
mannitol
glyceryl dibehenate
lactose monohydrate
hydrogenated castor oil
povidone
sodium lauryl sulfate
magnesium silicate
magnesium stearate
silicon dioxide
triethyl citrate
titanium dioxide
polydextrose
triacetin
polyethylene glycol 8000
vinyl acetate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0710 AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide